Living with Neuroendocrine Tumors
People with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day.
made one or more lifestyle changes due to NETs2
0
%
report general fatigue/muscle weakness2
0
%
experienced diarrhea2
0
%
The latest in NETRF News
NETRF Research News March 2025
This quarter, our topics include applying for NETRF research grants, CAR T-cell trial updates, save
FDA Grants Priority Review to Belzutifan as Pheo/Para Treatment
The U.S. Food and Drug Administration (FDA) has granted priority review to Merck’s application for
Advancing NET Treatment: A New Molecule for More Effective Targeted Alpha Therapy
In 2021, NETRF funded Paul Schaffer, PhD, of the University of British Columbia, for a
Attend a NET patient conference
Find support groups in your area
Check out patient advocacy groups
2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.